SALEM INVESTMENT COUNSELORS INC
Position in GALT — Galectin Therapeutics Inc
CIK 884423
WINSTON-SALEM, NC
Position in GALT
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$774
+$309 QoQ
Shares Held
167
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 7 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $2,462,425 across 22 Biotechnology names. GALT ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
100,000 | $1,782,000 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
494 | $245,384 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
5,746 | $99,980 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
2,288 | $89,254 | |
| 5 | INCY |
Incyte Corp
|
779 | $88,307 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
2,675 | $45,394 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
1,000 | $32,230 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
535 | $29,178 |
All Filings in GALT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774 | 167 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $465 | 167 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $708 | 167 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $352 | 167 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $203 | 167 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $215 | 167 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $459 | 167 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $377 | 167 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $399 | 167 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $277 | 167 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $320 | 167 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $240 | 167 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $350 | 167 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $188 | 167 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $272 | 167 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $218 | 167 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $268 | 167 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $345 | 167 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $647 | 167 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $534 | 167 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $362 | 167 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $374 | 167 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $445 | 167 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $511 | 167 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $327 | 167 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||